Langdon W Y, Shellam G R, Morgan G M, McKenzie I F
Immunogenetics. 1980;10(2):141-50. doi: 10.1007/BF01561563.
The radioimmune precipitation (RIP) assay was used to examine the antibody titres against endogenous AKR murine leukaemia virus (MuLV) in a number of antisera to lymphocyte (Ly) alloantigens. The sera from normal donor and unimmunized recipient mice used in raising the alloantisera were also examined for anti-MuLV activity. It was found that all the antisera had high anti-MuLV titres and that in all but one case alloantigen immunization augmented the anti-viral titres. The degree of augmentation did not appear to be related to the anti-MuLV titre in the donor strain sera. Three I-region antisera were also examined for anti-MuLV antibodies and were found to have lower anti-viral titres than the Ly antisera even though immunization to I-region products greatly augmented the anti-viral titre. These results caution against the use of Ly antisera in characterizing the phenotype of lymphoid tumour cells without prior virus absorption.
采用放射免疫沉淀(RIP)试验检测了多种淋巴细胞(Ly)同种异体抗原抗血清中针对内源性AKR鼠白血病病毒(MuLV)的抗体效价。还检测了用于制备同种异体抗血清的正常供体和未免疫受体小鼠血清的抗MuLV活性。结果发现,所有抗血清均具有较高的抗MuLV效价,除1例以外,在所有情况下,同种异体抗原免疫均提高了抗病毒效价。提高的程度似乎与供体品系血清中的抗MuLV效价无关。还检测了3种I区抗血清的抗MuLV抗体,发现其抗病毒效价比Ly抗血清低,尽管对I区产物的免疫大大提高了抗病毒效价。这些结果提醒在未事先进行病毒吸附的情况下,切勿使用Ly抗血清来鉴定淋巴肿瘤细胞的表型。